Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 339

1.

Effects of recent and reference antipsychotic agents at human dopamine D2 and D3 receptor signaling in Chinese hamster ovary cells.

Vanhauwe JF, Ercken M, van de Wiel D, Jurzak M, Leysen JE.

Psychopharmacology (Berl). 2000 Jul;150(4):383-90.

PMID:
10958079
2.
3.

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE.

Psychopharmacology (Berl). 1996 Mar;124(1-2):57-73.

PMID:
8935801
4.
5.

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.

Newman-Tancredi A, Gavaudan S, Conte C, Chaput C, Touzard M, Verrièle L, Audinot V, Millan MJ.

Eur J Pharmacol. 1998 Aug 21;355(2-3):245-56.

PMID:
9760039
6.

Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.

Jordan S, Johnson JL, Regardie K, Chen R, Koprivica V, Tadori Y, Kambayashi J, Kitagawa H, Kikuchi T.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):348-56. Epub 2006 Oct 27.

PMID:
17070976
7.

In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.

Hidaka K, Tada S, Matsumoto M, Ohmori J, Tasaki Y, Nomura T, Usuda S, Yamaguchi T.

Br J Pharmacol. 1996 Apr;117(8):1625-32.

9.

Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors.

Newman-Tancredi A, Cussac D, Audinot V, Millan MJ.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Jun;359(6):447-53.

PMID:
10431754
10.

In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.

Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC.

Synapse. 2006 Dec 15;60(8):599-608.

PMID:
17001660
11.
12.

Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.

Leysen JE, Janssen PM, Megens AA, Schotte A.

J Clin Psychiatry. 1994 May;55 Suppl:5-12.

PMID:
7520908
13.

Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.

Odagaki Y, Toyoshima R.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1304-12. Epub 2006 Jul 7.

PMID:
16824659
14.

Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.

Newman-Tancredi A, Rivet JM, Cussac D, Touzard M, Chaput C, Marini L, Millan MJ.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Sep;368(3):188-99. Epub 2003 Aug 16.

PMID:
12923612
15.
16.

Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.

Sóvágó J, Makkai B, Gulyás B, Hall H.

Eur J Neurosci. 2005 Jul;22(1):65-71.

PMID:
16029196
17.

Expression and pharmacological characterization of the human D3 dopamine receptor.

Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, McAllister G.

J Pharmacol Exp Ther. 1994 Jan;268(1):417-26.

PMID:
8301582
18.

Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.

Chio CL, Lajiness ME, Huff RM.

Mol Pharmacol. 1994 Jan;45(1):51-60.

PMID:
8302280
19.

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15.

Kiss B, Laszlovszky I, Horváth A, Némethy Z, Schmidt E, Bugovics G, Fazekas K, Gyertyán I, Agai-Csongor E, Domány G, Szombathelyi Z.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Nov;378(5):515-28. doi: 10.1007/s00210-008-0308-5. Epub 2008 Jun 13.

PMID:
18551280
20.

Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.

Cussac D, Duqueyroix D, Newman-Tancredi A, Millan MJ.

Psychopharmacology (Berl). 2002 Jul;162(2):168-77. Epub 2002 Apr 30.

PMID:
12110994

Supplemental Content

Support Center